- Home
- CHR vs NLSP Comparison
CHR vs NLSP Comparison
Compare CHR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- NLSP
- Stock Information
- Founded
- CHR 2016
- NLSP 2015
- Country
- CHR China
- NLSP Switzerland
- Employees
- CHR N/A
- NLSP N/A
- Industry
- CHR EDP Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- NLSP Health Care
- Exchange
- CHR Nasdaq
- NLSP Nasdaq
- Market Cap
- CHR 12.9M
- NLSP 12.4M
- IPO Year
- CHR N/A
- NLSP 2021
- Fundamental
- Price
- CHR $1.18
- NLSP $2.63
- Analyst Decision
- CHR
- NLSP
- Analyst Count
- CHR 0
- NLSP 0
- Target Price
- CHR N/A
- NLSP N/A
- AVG Volume (30 Days)
- CHR 87.5K
- NLSP 162.6K
- Earning Date
- CHR 07-30-2025
- NLSP 10-17-2025
- Dividend Yield
- CHR N/A
- NLSP N/A
- EPS Growth
- CHR N/A
- NLSP N/A
- EPS
- CHR 1.76
- NLSP N/A
- Revenue
- CHR $147,134,000.00
- NLSP N/A
- Revenue This Year
- CHR N/A
- NLSP N/A
- Revenue Next Year
- CHR N/A
- NLSP N/A
- P/E Ratio
- CHR $0.67
- NLSP N/A
- Revenue Growth
- CHR N/A
- NLSP N/A
- 52 Week Low
- CHR $1.00
- NLSP $1.30
- 52 Week High
- CHR $3.45
- NLSP $7.40
- Technical
- Relative Strength Index (RSI)
- CHR 37.15
- NLSP 60.48
- Support Level
- CHR $1.08
- NLSP $2.35
- Resistance Level
- CHR $2.03
- NLSP $2.65
- Average True Range (ATR)
- CHR 0.09
- NLSP 0.21
- MACD
- CHR -0.03
- NLSP 0.07
- Stochastic Oscillator
- CHR 13.16
- NLSP 84.16
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.